John R Su1, Pedro L Moro2, Carmen S Ng2, Paige W Lewis2, Maria A Said3, Maria V Cano2. 1. Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Ga. Electronic address: ezu2@cdc.gov. 2. Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Ga. 3. Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Md.
Abstract
BACKGROUND: Anaphylaxis, a rare and potentially life-threatening hypersensitivity reaction, can occur after vaccination. OBJECTIVE: We sought to describe reports of anaphylaxis after vaccination made to the Vaccine Adverse Event Reporting System (VAERS) during 1990-2016. METHODS: We identified domestic reports of anaphylaxis within VAERS using a combination of Medical Dictionary for Regulatory Activity queries and Preferred Terms. We performed a descriptive analysis, including history of hypersensitivity (anaphylaxis, respiratory allergies, and drug allergies) and vaccines given. We reviewed all serious reports and all nonserious reports with available medical records to determine if they met the Brighton Collaboration case definition for anaphylaxis or received a physician's diagnosis. RESULTS: During the analytic period, VAERS received 467,960 total reports; 828 met the Brighton Collaboration case definition or received a physician's diagnosis of anaphylaxis: 654 (79%) were classified as serious, and 669 (81%) had medical records available. Of 478 reports in children aged less than 19 years, 65% were male; childhood vaccines were most commonly reported. Of 350 reports in persons aged 19 years or greater, 80% were female, and influenza vaccines were most frequently reported. Overall, 41% of reports described persons with no history of hypersensitivity. We identified 8 deaths, 4 among persons with no history of hypersensitivity. CONCLUSION: Anaphylaxis after vaccination is rare in the United States and can occur among persons with no history of hypersensitivity. Most persons recover fully with treatment, but serious complications, including death, can occur. Published by Elsevier Inc.
BACKGROUND:Anaphylaxis, a rare and potentially life-threatening hypersensitivity reaction, can occur after vaccination. OBJECTIVE: We sought to describe reports of anaphylaxis after vaccination made to the Vaccine Adverse Event Reporting System (VAERS) during 1990-2016. METHODS: We identified domestic reports of anaphylaxis within VAERS using a combination of Medical Dictionary for Regulatory Activity queries and Preferred Terms. We performed a descriptive analysis, including history of hypersensitivity (anaphylaxis, respiratory allergies, and drug allergies) and vaccines given. We reviewed all serious reports and all nonserious reports with available medical records to determine if they met the Brighton Collaboration case definition for anaphylaxis or received a physician's diagnosis. RESULTS: During the analytic period, VAERS received 467,960 total reports; 828 met the Brighton Collaboration case definition or received a physician's diagnosis of anaphylaxis: 654 (79%) were classified as serious, and 669 (81%) had medical records available. Of 478 reports in children aged less than 19 years, 65% were male; childhood vaccines were most commonly reported. Of 350 reports in persons aged 19 years or greater, 80% were female, and influenza vaccines were most frequently reported. Overall, 41% of reports described persons with no history of hypersensitivity. We identified 8 deaths, 4 among persons with no history of hypersensitivity. CONCLUSION:Anaphylaxis after vaccination is rare in the United States and can occur among persons with no history of hypersensitivity. Most persons recover fully with treatment, but serious complications, including death, can occur. Published by Elsevier Inc.
Authors: Frederick Varricchio; John Iskander; Frank Destefano; Robert Ball; Robert Pless; M Miles Braun; Robert T Chen Journal: Pediatr Infect Dis J Date: 2004-04 Impact factor: 2.129
Authors: Vitali Pool; M Miles Braun; John M Kelso; Gina Mootrey; Robert T Chen; John W Yunginger; Robert M Jacobson; Paul M Gargiullo Journal: Pediatrics Date: 2002-12 Impact factor: 7.124
Authors: P R Criado; R de Oliveira Ramos; C Vasconcellos; R F Jardim Criado; N Y S Valente Journal: J Eur Acad Dermatol Venereol Date: 2004-09 Impact factor: 6.166
Authors: Kari Bohlke; Robert L Davis; S M Marcy; M M Braun; Frank DeStefano; Steven B Black; John P Mullooly; Robert S Thompson Journal: Pediatrics Date: 2003-10 Impact factor: 7.124
Authors: Silvia Perez-Vilar; Graça M Dores; Paige L Marquez; Carmen S Ng; Maria V Cano; Anuja Rastogi; Lucia Lee; John R Su; Jonathan Duffy Journal: Vaccine Date: 2021-12-07 Impact factor: 3.641
Authors: Jonathan Duffy; Paige Marquez; Graça M Dores; Carmen Ng; John Su; Maria Cano; Silvia Perez-Vilar Journal: Open Forum Infect Dis Date: 2020-10-27 Impact factor: 3.835
Authors: Matthew Greenhawt; Elissa M Abrams; Marcus Shaker; Derek K Chu; David Kahn; Cem Akin; Waleed Alqurashi; Peter Arkwright; James L Baldwin; Moshe Ben-Shoshan; Jonathan Bernstein; Theresa Bingeman; Katerina Blumchen; Aideen Byrne; Antonio Bognanni; Dianne Campbell; Ronna Campbell; Zain Chagla; Edmond S Chan; Jeffrey Chan; Pasquale Comberiatti; Timothy E Dribin; Anne K Ellis; David M Fleischer; Adam Fox; Pamela A Frischmeyer-Guerrerio; Remi Gagnon; Mitchell H Grayson; Caroline C Horner; Johnathan Hourihane; Constance H Katelaris; Harold Kim; John M Kelso; David Lang; Dennis Ledford; Michael Levin; Jay Lieberman; Richard Loh; Doug Mack; Bruce Mazer; Gissele Mosnaim; Daniel Munblit; S Shahzad Mustafa; Anil Nanda; John Oppenheimer; Kirsten P Perrett; Allison Ramsey; Matt Rank; Kara Robertson; Javed Shiek; Jonathan M Spergel; David Stukus; Mimi Lk Tang; James M Tracy; Paul J Turner; Anna Whalen-Browne; Dana Wallace; Julie Wang; Susan Wasserman; John K Witty; Margitta Worm; Timothy K Vander Leek; David Bk Golden Journal: J Allergy Clin Immunol Pract Date: 2021-06-18